No connection

Search Results

BTMD vs FORA

BTMD
biote Corp.
NEUTRAL
Price
$1.49
Market Cap
$55.5M
Sector
Healthcare
AI Confidence
85%
FORA
Forian Inc.
BEARISH
Price
$2.14
Market Cap
$66.9M
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
BTMD
2.01
FORA
--
Forward P/E
BTMD
2.61
FORA
23.78
P/B Ratio
BTMD
-0.78
FORA
2.23
P/S Ratio
BTMD
0.29
FORA
2.21
EV/EBITDA
BTMD
3.84
FORA
-9.93

Profitability

Gross Margin
BTMD
71.46%
FORA
53.21%
Operating Margin
BTMD
9.4%
FORA
-24.44%
Profit Margin
BTMD
14.07%
FORA
-9.5%
ROE
BTMD
--
FORA
-9.61%
ROA
BTMD
19.06%
FORA
-5.15%

Growth

Revenue Growth
BTMD
-6.9%
FORA
37.0%
Earnings Growth
BTMD
-36.7%
FORA
--

Financial Health

Debt/Equity
BTMD
--
FORA
0.0
Current Ratio
BTMD
1.22
FORA
2.96
Quick Ratio
BTMD
0.71
FORA
2.78

Dividends

Dividend Yield
BTMD
--
FORA
--
Payout Ratio
BTMD
0.0%
FORA
0.0%

AI Verdict

BTMD NEUTRAL

BTMD shows neutral fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Mixed signals with both opportunities and risks present.

Strengths
Attractive valuation with P/E of 2.0
Risks
Declining revenue (-6.9%)
FORA BEARISH

FORA exhibits severe fundamental weakness as evidenced by a Piotroski F-Score of 2/9, indicating poor operational efficiency and financial health. While the company maintains a debt-free balance sheet and strong liquidity (Current Ratio 2.96), it is struggling to translate 37% revenue growth into bottom-line profitability. The technical trend is completely bearish (0/100) and the 5-year price performance is devastating (-82.8%), suggesting a long-term loss of investor confidence. Despite a healthy gross margin of 53.21%, the negative operating margins and lack of deterministic value markers make this a high-risk speculative play.

Strengths
Zero debt (Debt/Equity: 0.00)
Strong short-term liquidity (Current Ratio: 2.96)
Robust revenue growth (37% YoY)
Risks
Critically low Piotroski F-Score (2/9) indicating fundamental deterioration
Negative operating margins (-24.44%)
Severe long-term price depreciation (-82.8% over 5 years)

Compare Another Pair

BTMD vs FORA: Head-to-Head Comparison

This page compares biote Corp. (BTMD) and Forian Inc. (FORA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile